As of 2025-07-09, the EV/EBITDA ratio of Codiak BioSciences, Inc. (CDAK) is 0.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CDAK's latest enterprise value is -21.30 mil USD. CDAK's TTM EBITDA according to its financial statements is -62.43 mil USD. Dividing these 2 quantities gives us the above CDAK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 16.7x | 13.9x |
| Forward P/E multiples | 10.9x - 26.1x | 16.0x |
| Fair Price | (9.63) - (12.13) | (10.86) |
| Upside | -16988.2% - -21386.1% | -19154.4% |
| Date | EV/EBITDA |